Delivery Order SPE2DE24D0013-SPE2D626F38PM
- Not listed
- The Department of Defense's Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $20,994.88 to Cepheid Inc. on January 23, 2026, for diagnostic reagents and test kits under a firm fixed-price arrangement with no set-aside designation. This delivery order, which is expected to be completed by January 30, 2026, represents a child contract issued against Cepheid's larger Indefinite Delivery Contract (IDC) with the Veterans Integrated Service Network (VISN) 6, valued at...
- The Defense Logistics Agency Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc. on January 21, 2026, for diagnostic reagents and test kits. This delivery order, valued at the ceiling amount, represents a child contract under Cepheid's larger Indefinite Delivery Contract (IDC) vehicle with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, which is valued at $6.74 million through December 28, 2029. The delivery order is for...
- The Defense Logistics Agency Medical Supply Chain awarded a $40.8K delivery order to Cepheid Inc. on January 27, 2026, for molecular diagnostic reagents and test kits under the XPRS4PLEX-10 contract vehicle. This delivery order, which is a child contract with a firm fixed-price structure and no set-aside designation, is scheduled for completion by February 3, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. The award represents continued procurement of diagnostic...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on January 20, 2026, with an ultimate completion date of January 27, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract framework with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.74 million through December 28, 2029. The delivery order procures...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, identified as XPRS4PLEX-10, is a child contract issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030. The contract involves the supply of molecular diagnostic testing...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a $5,184 firm fixed-price delivery order on January 30, 2026, for diagnostic testing supplies and reagents. This delivery order, valued at the ceiling amount, is a child contract issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 6 (VISN 6), which carries a total value of approximately $32.8 million through September 30, 2030. The contract...
- The Defense Logistics Agency Medical Supply Chain awarded a $20,879.88 firm fixed-price delivery order to Cepheid Inc. on January 30, 2026, for molecular diagnostic reagents and test kits. This delivery order, designated XPRS4PLEX-10, is scheduled for completion by February 6, 2026, and will be performed at Cepheid's headquarters in Sunnyvale, California. The award represents a child contract issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs...
- On January 30, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $2,040 to Cepheid Inc. for diagnostic reagents and test kits. This delivery order, designated XPRS4PLEX-10, is a child contract under Cepheid's single-award Indefinite Delivery Contract with the Department of Veterans Affairs' VISN 17, valued at $6.7M and extending through December 28, 2029. The contract utilizes a firm fixed-price structure with no set-aside designation and requires...
- The Defense Logistics Agency Medical Supply Chain awarded a $9,520 firm fixed-price delivery order to Cepheid Inc. on January 23, 2026, with an ultimate completion date of January 30, 2026. This delivery order, designated XPRS4PLEX-10, is a child contract issued under Cepheid's larger Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network 17, valued at $6.7 million through December 28, 2029. The delivery order procures diagnostic reagents and...
- The Defense Logistics Agency Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc. on January 29, 2026, for diagnostic supplies and reagents. This delivery order, valued at $8,160 with an ultimate completion date of February 5, 2026, represents a child contract under Cepheid's larger Indefinite Delivery Contract (IDC) with the Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030. The delivery order includes XPRS4PLEX-10...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F38PMDelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc. on February 1, 2026, for diagnostic reagents and test kits under the contract identifier XPRS4PLEX-10, with ultimate completion scheduled for February 6, 2026. This delivery order represents a child contract issued under Cepheid's broader Indefinite Delivery Vehicle with the Department of Veterans Affairs VISN 17, valued at $6.74 million through December 28, 2029, which establishes the framework for procurement of molecular diagnostic solutions including XPRS4PLEX-10 cartridges and other respiratory pathogen testing supplies. The contract does not utilize a set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid has positioned itself as a primary federal supplier of advanced molecular diagnostic systems and reagents, with particular expertise in the GeneXpert diagnostic platform for detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other respiratory pathogens. The company maintains extensive federal contracting relationships across multiple healthcare agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency, demonstrating substantial capability in supplying diagnostic equipment, testing kits, reagents, and maintenance services to support clinical laboratory operations and infectious disease detection requirements across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 1/31/26 |